Celldom is developing next generation, high throughput single cell analysis technology to advance research, drug discovery, and drug development by illuminating diversity in cell populations. The company's cloneXplorer and proprietary nanowell plates uniquely integrates both phenotypic and genomic data at massive scale (up to 100,000s of cells per experiment) to identify and characterize rare cells that play critical roles in biological pathways and disease. Celldom is developing initial applications of the platform in the areas of oncology, immunology and stem cell biology. Learn more at www.celldom.com and follow the company's growth @celldominc on Twitter.
Looking for a particular Celldom, Inc. employee's phone or email?
The Celldom, Inc. annual revenue was $608000 in 2026.
Benjamin Yellen is the CEO of Celldom, Inc..
6 people are employed at Celldom, Inc..
Celldom, Inc. is based in San Carlos, California.
The NAICS codes for Celldom, Inc. are [541, 54171, 5417, 54, 541714].
The SIC codes for Celldom, Inc. are [87, 873].